Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwide

1

Introduction Aarkstore Enterprise
Our comprehensive and wide range of databank in
the field of Market Research Report provides
exclusive, pioneering and innovative service to
our report buyers. Our high-quality databank
comprises of company profiles, strategy review,
company report, industry reports, company
financials, industry research, SWOT analysis, and
so on Aarkstore.com is in the forefront as it
is enriched with comprehensive informative and
interactive search features. One can browse to
have ample access of beyond 2.5 lakh business
industry reports.
2
Category

• Pharmaceuticals Healthcare Market Research
  Reports http//www.aarkstore.co
  m/market-sector-reports/Pharmaceuticals--Healthca
  re-7.html

3
Report
2013 Risk Sharing and Other Forms of Managed
Entry Agreements Aarkstore.in
http//aarkstore.in/Risk-Sharing-and-Other-Form
s-of-Managed-Entry-Agreements.html
4
Request Sample
http//www.aarkstore.com/Report/SampleRequest.asp?
RptId242105
5
Summary

• Managed entry agreements apply to an
  increasing number of new, innovative drugs in a
  growing number of markets. They are designed to
  share the risk between the manufacturer and the
  payer, consequent on uncertainties - usually at
  launch - about the products value (clinical- and
  cost-effectiveness), budget impact and/or
  utilisation to optimise performance, whilst at
  the same time allowing patient access. For many
  products considered costly they are almost
  essential to achieve reimbursement where health
  technology assessment is applied.
  
  More

6
Table of Contents

• Executive Summary1. What are
  Risk-Sharing Agreements?Dealing with uncertainty
  Categorisation Performance-based
  schemesFinance-based schemes Managed entry
  agreementsIndustry wish list2. Europe Belgium
  Czech Republic
  More

7
Latest Reports
http//www.aarkstore.com/publishers/JustPharmaRe
ports-12.htmlRisk Sharing and Other Forms of
Managed Entry Agreements for Medicines,
Worldwide  Pharmaceutical Pricing
Distribution in Japan, 2012 Update  Biosimilars
Current Situation Future Prospects,
Worldwide  Orphan Drugs in Europe Pricing,
Reimbursement, Funding Market Access Issues,
2011 Edition  Market Access Korea Breaking
into the Developed Worlds Fastest Growing
Pharmaceutical Market
8
(No Transcript)
9
Contact us
For More details about above other Reports
please contact Lavanya Aarkstore.com Contact
Marketing team Mob.No.918149852585 Email
Customersupport_at_aarkstore.com URL
http//www.aarkstore.com
http//aarkstore.in/